Bisoprolol ist einer der am häufigsten verordneten Betablocker in Deutschland – über 15 Millionen Verordnungen pro Jahr. Er verlangsamt den Herzschlag, senkt den Blutdruck und schützt das Herz bei Herzschwäche und nach Herzinfarkt. Gleichzeitig führt er bei vielen Patienten zu Müdigkeit und kühlen Händen – und darf niemals plötzlich abgesetzt werden.
.gif)
This article is for informational purposes only and does not replace medical advice. Bisoprolol is a prescription medication. Never change the dose or stop taking it without consulting your doctor.
Bisoprolol is one of the most widely prescribed beta-blockers in the world and is considered the beta-blocker of first choice by the British Heart Foundation. This is due to its unique combination of high cardiac selectivity, long half-life, and broad range of indications — from high blood pressure and heart rhythm disturbances to chronic heart failure.
| Property | Details |
|---|---|
| Active substance | Bisoprolol fumarate |
| ATC code | C07AB07 (beta-adrenoceptor antagonist, selective) |
| Drug class | Cardioselective beta-1-blocker (beta-blocker) |
| Available forms | Tablets (1.25 mg, 2.5 mg, 3.75 mg, 5 mg, 7.5 mg, 10 mg) |
| Half-life | 10–12 hours |
| Max. daily dose | 10 mg (hypertension); 10 mg (heart failure — titrated slowly) |
| Onset of action | 1–2 hours; maximum effect after approx. 2 weeks |
| Prescription only | Yes |
| Special feature | Highest beta-1 selectivity among beta-blockers; once-daily dosing |
Bisoprolol is licensed for: arterial hypertension (high blood pressure), stable chronic angina pectoris (chest tightness due to coronary artery disease), stable chronic heart failure in combination with ACE inhibitors and diuretics, tachycardic heart rhythm disturbances, and secondary prevention after heart attack.
To understand why bisoprolol is so versatile, it helps to understand the physiology of the heart. The heart is equipped with beta-1 receptors — docking sites for the stress hormones adrenaline and noradrenaline. When these hormones arrive, the heart beats faster and more forcefully: the classic stress or anxiety response. Bisoprolol occupies these receptors and blocks them — the stress hormones find no free binding site and cannot exert their effect.
Negatively chronotropic — the heart beats more slowly. This is the effect most patients notice first: resting heart rate falls. A slower pulse means the heart needs less oxygen per minute — a major advantage in coronary artery disease, where oxygen supply is already restricted. In many patients, resting heart rate drops to 55–65 beats per minute, which is entirely normal and desired.
Negatively inotropic — the heart beats with less force. This may sound alarming, but in heart failure it is exactly right: an overloaded heart under chronically elevated adrenaline activity is relieved by bisoprolol. Over time, heart function can actually improve — the paradox of beta-blocker therapy in heart failure, convincingly demonstrated by the CIBIS-II trial.
Negatively dromotropic — conduction is slowed. The heart has an electrical conduction system that coordinates the heartbeat. When this system loses rhythm — for example in atrial fibrillation — bisoprolol can help slow conduction and stabilise heart rhythm.
Blood pressure lowering through two mechanisms. First, reduced cardiac output directly lowers blood pressure. Second, bisoprolol inhibits renin release in the kidneys — a hormone that regulates blood pressure via the renin-angiotensin-aldosterone system (RAAS). The combination of both effects makes bisoprolol particularly effective for high blood pressure.
Not all beta-blockers are equal. Older, non-selective beta-blockers (such as propranolol) block both beta-1 and beta-2 receptors. Beta-2 receptors sit in the bronchial tubes and control their dilation — when blocked, the airways can narrow. This is why older beta-blockers were contraindicated in asthmatics. Bisoprolol has the highest beta-1 selectivity of all commonly used beta-blockers — it concentrates its effect maximally on the heart while largely leaving the bronchi alone. In severe asthma, bisoprolol nevertheless remains contraindicated, because even minor beta-2 blockade would be too dangerous in this case.
For hypertension and stable angina pectoris, dosing is straightforward: begin with 5 mg daily and increase after 1–2 weeks to 10 mg if blood pressure is not adequately reduced. A maximum dose of 20 mg is rarely needed and only appropriate under medical supervision. Most patients do well with 5–10 mg.
In heart failure, patience is the most important virtue. The starting dose is only 1.25 mg daily — a dose that seems unusually small to many patients. The reason: a weakened heart reacts sensitively to any change. The dose is increased stepwise every two weeks, provided it is well tolerated.
| Week | Dose | Note |
|---|---|---|
| Weeks 1–2 | 1.25 mg/day | Starting dose — begin very low! |
| Weeks 3–4 | 2.5 mg/day | Only increase if well tolerated |
| Weeks 5–8 | 3.75 mg/day | Monitor pulse and blood pressure |
| Weeks 9–12 | 5 mg/day | – |
| From week 13 | 7.5–10 mg/day | Target dose: 10 mg/day |
Bisoprolol is taken once daily in the morning — with or without breakfast, either is fine. The tablet should be swallowed whole with a glass of water. What many patients initially underestimate: consistency matters more than the exact time. Anyone taking bisoprolol once daily should do so at the same time every day — this stabilises drug levels in the blood and prevents fluctuations. A dose reminder helps considerably.
What to do if a dose has been missed? Take the forgotten tablet as soon as possible — but only if the next dose is still more than 8 hours away. If the next dose is due soon, simply skip it and continue as normal. Never take two tablets at once to make up for a missed dose. This can cause a dangerous drop in blood pressure or pronounced bradycardia.
An important monitoring point in everyday life is resting heart rate. Bisoprolol lowers heart rate — this is intended and normal. However, if resting heart rate falls below 50 beats per minute, the doctor should be informed. Many patients check their pulse in the morning after waking, before getting up. This provides a reliable baseline value. For dizziness, shortness of breath, or unusual weakness, the doctor should also be contacted.
Before any planned surgery or procedure, it is important to inform the anaesthetist about bisoprolol use. Bisoprolol should generally not be stopped before surgery — abrupt discontinuation would trigger the rebound risk (more on this in chapter 6). The anaesthetist must however know that the heart is under beta-blocker therapy, as this influences anaesthetic management.
Bisoprolol is generally well tolerated — better than many older beta-blockers. There are nevertheless typical side effects, particularly in the first few weeks, that patients should be familiar with. The most important point: most symptoms improve significantly after 2–4 weeks as the body adjusts to the changed cardiac output.
The most common complaint is fatigue — especially in the first few weeks. The heart pumps with less force, blood pressure drops, and the body needs time to adapt. Many patients report feeling "wrapped in cotton wool" or running out of energy more quickly with everyday exertion. This is normal during the initial phase. What helps: taking bisoprolol in the morning rather than the evening (some patients sleep better with evening intake, others feel more tired during the day). Light physical activity can paradoxically reduce fatigue by stimulating circulation.
A slower pulse is the desired effect of bisoprolol — not a side effect. It only becomes problematic if resting heart rate persistently falls below 50 beats per minute, or if the slow pulse is accompanied by symptoms such as dizziness, near-fainting, or extreme weakness. In this case, the doctor must adjust the dose. A pulse between 50 and 60 with no symptoms is entirely acceptable and actually shows the medication is working.
Bisoprolol reduces peripheral circulation — blood vessels in the hands and feet constrict slightly. This is harmless but particularly unpleasant in winter. Warm gloves and socks and avoiding cold exposure help. Anyone with Raynaud's phenomenon (strong whitening of the fingers in the cold) should discuss this with their doctor — switching to nebivolol may be appropriate, as it actually promotes vasodilation through nitric oxide release.
| Side effect | Frequency | What to do |
|---|---|---|
| Fatigue / exhaustion | Common | Improves after 2–4 weeks. Morning intake helps some patients. |
| Bradycardia (slow pulse) | Very common (in HF) | Pulse < 50/min: inform doctor. Dose reduction may be needed. |
| Dizziness / low blood pressure | Common | Especially at start of therapy. Rise slowly from sitting/lying! |
| Headaches | Common | Usually temporary |
| Cold hands and feet | Common | Warm clothing. Discuss with doctor if Raynaud's is present. |
| Nausea, gastrointestinal | Common | Taking with breakfast may help |
| Sleep disturbances / vivid dreams | Occasional | Less common than with metoprolol (less lipophilic) |
| Low mood / depression | Occasional | If persistent mood changes: inform doctor |
| Erectile dysfunction | Occasional | Often not raised — doctor can find an alternative (nebivolol) |
| Reduced tear production | Rare | Important for contact lens wearers |
A topic that is often avoided: erectile dysfunction under bisoprolol. Studies show that up to 10% of male patients develop sexual dysfunction under beta-blockers. Many people affected do not raise this and stop the medication secretly — which, as described, can be life-threatening. Anyone experiencing this problem should raise it openly with their doctor. Nebivolol is significantly better tolerated in this regard because it improves blood flow through nitric oxide release. Use brite's side-effect log to document all symptoms.
This is not a theoretical risk — it is a documented clinical reality. In the brite app, the discontinuation warning is one of the most frequently displayed alerts, because many patients interrupt the course when they feel better or when side effects are troublesome. Even missing doses for several days can trigger this effect.
Bisoprolol should be reduced stepwise over at least 2–4 weeks. The rule of thumb: halve the dose at each step and wait at least one week before reducing further.
| Current dose | Week 1 | Week 2 | Week 3 | Then |
|---|---|---|---|---|
| 10 mg | 7.5 mg | 5 mg | 2.5 mg | 1.25 mg, then stop |
| 5 mg | 3.75 mg | 2.5 mg | 1.25 mg | Stop |
| 2.5 mg | 1.25 mg | 1.25 mg every other day | – | Stop |
During tapering, pulse and blood pressure should be checked regularly. If palpitations, chest pain, or a significant rise in blood pressure occurs, contact your doctor immediately. Tapering must only take place under medical supervision — never on your own. Record every dose step in your digital medication plan so your doctor always has a clear overview.
Bisoprolol interacts with a number of medications, some of which are potentially life-threatening. The most important rule: inform every doctor and pharmacist about your bisoprolol — including for seemingly harmless painkillers or over-the-counter products. Check all your combinations with the interaction check.
Verapamil and diltiazem (so-called non-dihydropyridine calcium channel blockers) have similar effects on the heart as bisoprolol — both slow heart rate and reduce conduction. When given together, they can dangerously potentiate each other: the result can be severe bradycardia, AV block, or heart failure. The combination is absolutely contraindicated when given intravenously. Oral use is only possible under strict cardiological monitoring. Amlodipine, by contrast, is a safe combination partner — it belongs to the dihydropyridine calcium channel blockers, which have no negatively chronotropic effect.
Ibuprofen, diclofenac, and other non-steroidal anti-inflammatory drugs (NSAIDs) can reduce the blood pressure-lowering effect of bisoprolol. This is because NSAIDs affect kidney function and increase sodium retention, which raises blood pressure again. Anyone who occasionally needs to treat headaches or back pain should switch to paracetamol (acetaminophen) — it does not affect blood pressure.
Bisoprolol can mask the symptoms of hypoglycaemia (low blood sugar) in diabetics on insulin therapy or sulphonylureas. Normally, the heart warns of low blood sugar with palpitations — this signal is absent under bisoprolol. What remains: sweating, which is reliably preserved as a warning sign. Diabetics on bisoprolol must therefore monitor their blood sugar more frequently and consistently.
| Substance / medication | Interaction | Recommendation |
|---|---|---|
| Verapamil / diltiazem | Strongly cardio-depressant: bradycardia, AV block, heart failure | Contraindicated i.v.; oral only under strict monitoring |
| Ibuprofen / diclofenac (NSAIDs) | Reduce blood pressure-lowering effect | Prefer paracetamol (acetaminophen) |
| Insulin / metformin / sulphonylureas | Enhances blood sugar-lowering effect AND masks hypoglycaemia symptoms | Monitor blood sugar more frequently; sweating remains as warning sign |
| ACE inhibitors (ramipril), amlodipine | Additive blood pressure lowering — desired but needs monitoring | Frequently used combination. Monitor blood pressure and pulse. |
| Digoxin | Increased bradycardia and AV conduction disturbance | Monitor digoxin levels; check pulse |
| Clonidine | Rebound hypertension on withdrawal | Taper bisoprolol first; then stop clonidine |
| Anaesthetic agents | Enhanced blood pressure drop under anaesthesia | Inform anaesthetist; as a rule, do NOT stop bisoprolol before surgery |
| Alcohol | Enhances blood pressure drop and fatigue | Alcohol in moderation, especially at start of therapy |
